Patent · US Active

HIV protease inhibitors

US9315475B2 · kind B2 · utility

4Cited by
7References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 9, 2013
Grant dateApr 19, 2016
Priority date—
Expiry dateJan 11, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F7/0814
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.